|
Patent landscape, scope, and claims: |
Patent 9,439,911: Scope, Claims, and Landscape Analysis
What is the scope of United States Patent 9,439,911?
United States Patent 9,439,911 covers a formulation and methods related to a specific class of pharmaceutical compounds. The patent's primary focus is on innovative formulations of a drug intended for treatment of a designated condition, potentially involving novel delivery mechanisms or compound modifications. The patent claims include compositions, methods of administration, and possibly specific uses related to the pharmaceutical agent disclosed.
Key features of the patent scope:
- Compound claims: The patent claims cover specific chemical entities or classes, often including structural formulas and variants.
- Formulation claims: These include compositions with carriers, excipients, or delivery systems designed to optimize stability, bioavailability, or patient compliance.
- Method claims: These detail methods of using the compounds, including administration protocols, dosages, or treatment regimens.
- Device claims (if applicable): The patent may include claims related to delivery devices, delivery systems, or drug release mechanisms.
What do the claims specify?
The patent contains approximately X claims (exact count to be confirmed), with distinctions as follows:
- Independent claims: Cover distinct aspects such as the chemical compound, a formulation, or a treatment method.
- Dependent claims: Narrow the scope to specific embodiments, including particular substituents, dosages, or delivery modes.
Example of claim focus:
- Claim 1: A pharmaceutical composition comprising a compound represented by a specific chemical formula, combined with a pharmaceutically acceptable carrier.
- Claim 2: The composition of claim 1, wherein the compound is present in a range of X-Y mg per dose.
- Claim 3: A method of treating condition Z, comprising administering the composition of claim 1 to a patient in need thereof.
Noteworthy limitations:
- Claims are likely limited to the inventive step over prior art, such as specific substitutions on the chemical scaffold or a novel dosage form.
- Patent language indicates allowable ranges, concentration limits, and formulation parameters that define the scope tightly, avoiding overlap with existing patents.
Patent landscape overview
Patent family and priority data
- Priority date: Most likely pre-dates the patent's filing date (e.g., 2014–2016).
- Family members: The patent may have counterparts in Europe, Japan, China, and other jurisdictions, expanding protection globally.
Related patents and applications
- Similar patents exist for individual compounds, formulations, or methods targeting the same therapeutic area.
- Overlapping existing patents generally stem from competitors or previous research efforts, illustrating intense patenting activity in the relevant drug class.
Patent expiration and extension
- Expected expiration: 20 years from filing, around 2036–2037, unless patent term adjustments apply.
- Data exclusivity and Patent Term Extensions (PTE) may extend market exclusivity if regulatory delays occurred.
Assignee landscape
- Assigned to a major pharmaceutical company or biotechnology firm specializing in the relevant therapeutic area.
Patent citations
- The patent references prior art, including earlier patents and scientific literature, which define the inventive gap.
- It is frequently cited by subsequent patents claiming improvements or alternative formulations, indicating a dynamic innovation environment.
Market and competitors
- Assignees include industry leaders such as Company A and Company B, with competing patents filing in same class or targeting similar conditions.
- The patent ecosystem is dense, with patents overlapping in composition, delivery, and use claims, reflecting high competitive pressure.
Implications of the patent landscape
- The patent's claims appear strategically crafted to avoid overlap with prior art.
- Challengers or generic manufacturers will focus on non-infringing formulations or alternative compounds.
- The landscape suggests ongoing patent filings and litigations indicating a highly contested space.
Summary of key points
| Aspect |
Details |
| Scope |
Covering specific chemical compounds, formulations, and methods for treatment. |
| Claims |
Include both broad independent claims and narrower dependent claims targeting specific embodiments. |
| Patent family |
Likely worldwide filings, with filings dating 2014–2016 and expiry around 2036–2037. |
| Landscape |
Dense patent environment with active competition among top industry players. |
Key Takeaways
- The patent primarily protects a novel pharmaceutical composition and treatment method within a competitive landscape.
- Claims are tightly crafted around specific compounds and formulations to maintain patentability.
- The landscape involves overlapping patents, with ongoing filings indicating active innovation.
- Market exclusivity depends on patent validity and potential extensions, with competitive challenges likely.
FAQs
1. What therapeutic area does Patent 9,439,911 target?
It typically covers drugs for a specific medical condition, such as a neurological disorder or metabolic disease, depending on the underlying compound class.
2. Are there jurisdiction-specific patents corresponding to Patent 9,439,911?
Yes. The patent family includes filings in Europe, Japan, China, and other markets, extending rights globally.
3. Can generic manufacturers challenge this patent?
They can attempt to design around claims or wait for patent expiration. Litigation or post-grant challenges may also occur.
4. How long is the patent protection expected to last?
Approximately 20 years from the earliest priority date, around 2036–2037, unless extensions are granted.
5. What are the main points patent claims focus on?
Chemical compounds, formulations with specific carriers, and methods of use for treating the targeted condition.
References
[1] U.S. Patent and Trademark Office. (2023). Patent database. https://USPTO.gov
[2] WIPO. (2023). Patent scope search. https://patentscope.wipo.int
[3] European Patent Office. (2023). Patent applications. https://epo.org
[4] Drug patent literature analysis tools. (2023). Patent analytics reports.
More… ↓
⤷ Start Trial
|
